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Introduction
Neurodegenerative disorders such as Huntington’s disease 
(HD) and Parkinson’s disease are characterized by the accumula-
tion of intracellular ubiquitin-containing protein aggregates. 
Although polyubiquitin is a well-known signal for degradation 
by the ubiquitin–proteasome system, several aggregation-prone 
proteins have been shown to disrupt the function of the protea-
some (Bence et al., 2001; Jana et al., 2001; Urushitani et al., 
2002; Snyder et al., 2003). Activation of an alternative lyso-
somal mechanism of protein degradation, known as macro-
autophagy (hereafter referred to as autophagy), is often observed in 
protein aggregation diseases (Ravikumar and Rubinsztein, 2004; 
Iwata et al., 2005; Yamamoto et al., 2006). Autophagy is a 
dynamic process whereby cytoplasmic material is sequestered 
within double membrane-enclosed vesicles (autophagosomes), 
which eventually fuse with lysosomes where the encapsulated 
material is degraded (Klionsky and Ohsumi, 1999). This path-
way is known to be important in developmental processes and 
human disease and for meeting amino acid poor growth condi-
tions (Klionsky and Emr, 2000). Recently, it was found that loss 
of autophagy causes neurodegeneration even in the absence of any 
disease-associated mutant proteins (Hara et al., 2006; Komatsu 
et al., 2006), suggesting that the continuous clearance of cellu-
lar proteins through basal autophagy prevents their accumula-
tion, and in turn prevents the disruption of neural function and 
subsequent neurodegeneration.
Autophagy is generally considered a ubiquitous bulk degra-
dation mechanism for long-lived proteins and organelles. The mo-
lecular mechanisms underlying the autophagic process have been 
extensively studied in yeast, using genetic screens to identify 
autophagy-defective (atg) and vacuolar protein sorting (vps) 
mutants (Klionsky et al., 2003). Subsequent inactivation of atg 
orthologues in higher eukaryotes has revealed that the auto-
phagic machinery is highly conserved. Nonetheless, the molecular 
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and of expanded polyglutamine aggregates associated 
with Huntington’s disease. Together, our data indicate that 
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served neurodegenerative phenotype seen in patients with 
CHMP2B mutations.
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mechanisms and signals involved in the recognition of auto-
phagic substrates and traffi  cking of autophagosomes are poorly 
understood.
The endosomal sorting complexes required for transport 
(ESCRTs), fi  rst identifi  ed by characterization of yeast vps class E 
mutants, have proven important for recognition of ubiquitinated 
endocytosed integral membrane proteins, their sorting into the 
intralumenal vesicles (ILVs) of the multivesicular body (MVB) 
and subsequent degradation in the lysosome/vacuole. Ubiqui-
tinated cargo is fi  rst recognized by the Vps27p/Hrs (hepatocyte 
growth factor–regulated tyrosine kinase substrate)–Hse1p/STAM 
(signal transducing adaptor molecule) complex. Vps27p/Hrs 
then recruits the ESCRT-I complex (Vps23p/Tsg101, Vps28p, 
Vps37p, Mvb12p) to the endosome membrane by binding Vps23p/
Tsg101 (tumor susceptibility gene 101). The ubiquitinated 
cargo is further assumed to be delivered to ESCRT-II (Vps22p, 
Vps25p, Vps36p) before it gets internalized into MVBs through 
the activity of ESCRT-III (Vps2p, Vps20p, Vps24p, Vps32p). 
Ubiquitin is removed proteolytically and the ESCRT machinery 
is fi  nally dissociated from the endosomal membrane by activity 
of the ATPase Vps4p/SKD1 (for review see Hurley and Emr, 2006; 
Slagsvold et al., 2006; Williams and Urbe, 2007).
Depletion of ESCRT subunits results in MVBs with ab-
normal morphology, called the “class E compartment” in yeast. 
The effects of depleting different ESCRT subunits on inter-
nalization and degradation of integral membrane proteins 
such as the epidermal growth factor receptor (EGFR) have been 
well characterized (Slagsvold et al., 2006). However, little is 
known about the role of functional MVBs and ESCRT subunits 
for autophagic degradation. The classical view has been that the 
autophagic and endocytic pathways converge at the lysosomal 
level, but autophagosomes have also been found to undergo 
fusions with earlier parts of the endocytic pathway (Tooze et al., 
1990; Punnonen et al., 1993; Liou et al., 1997; Berg et al., 1998). 
The term “amphisome” is used to describe pre-autolysosomal 
compartments containing both autophagic and endocytic ma-
terial (Gordon and Seglen, 1988), but the specifi  city of am-
phisome formation and the molecular mechanism involved 
are poorly understood.
Recently, the ESCRT-III subunit CHMP2B (charged multi-
vesicular body protein 2B, also known as chromatin-modifying 
protein 2B)/Vps2B was found to be mutated in a large Danish 
pedigree with frontotemporal dementia (FTD) (Skibinski et al., 
2005), and in patients with amyotrophic lateral sclerosis (ALS) 
(Parkinson et al., 2006). FTD is the second most common form of 
presenile dementia after Alzheimer’s disease (Ratnavalli et al., 
2002; Harvey et al., 2003) and is characterized neuropathologi-
cally by the presence of either tau pathology or ubiquitin pa-
thology, which is termed frontotemporal lobar degeneration with 
ubiquitin-immunoreactive inclusions (FTLD-U) (Neary et al., 
2005). The cellular pathologies of both FTLD-U and ALS demon-
strate accumulation of ubiquitin-positive protein deposits that are 
also positive for p62/Sequestosome-1, a common component of 
protein inclusions associated with neurodegenerative disease 
(Talbot and Ansorge, 2006). p62 can bind polyubiquitin through its 
UBA domain (Vadlamudi et al., 1996) and interacts with the auto-
phagic protein Atg8/LC3 (Bjorkoy et al., 2005; Pankiv et al., 2007), 
thus providing a possible link between protein accumulation and 
aggregation with autophagy-mediated clearance.
In light of the mutations found in CHMP2B, we asked 
whether the ESCRT machinery is required for autophagic deg-
radation and prevention of formation of protein aggregates as-
sociated with neurodegenerative disease. In this study we show that 
autophagic degradation is inhibited in cells depleted of ESCRT 
subunits and in cells overexpressing CHMP2B mutants, leading to 
accumulation of protein aggregates containing ubiquitinated pro-
teins, p62 and Alfy (autophagy-linked FYVE protein). Moreover, 
we show that TAR DNA-binding protein 43 (TDP-43), recently 
identifi  ed as the major ubiquitinated protein in FTLD-U and ALS, 
accumulates in ubiquitin-positive inclusions in ESCRT-depleted 
cells. Using conditional cell-based systems for HD, we fi  nd that 
functional MVBs are also required for effi  cient clearance of the 
expanded polyglutamine aggregates. Collectively, our data indicate 
that effi  cient autophagic degradation requires functional MVBs 
and provide a possible explanation to the observed neurodegenera-
tive phenotype seen in patients with CHMP2B mutations.
Results
Non-endosomal ubiquitin-positive 
structures accumulate in 
ESCRT-depleted cells
To investigate whether depletion of ESCRT subunits leads to 
accumulation of ubiquitinated proteins, HeLa cells transfected 
with siRNA against Hrs, ESCRT-I (Tsg101), -II (Vps22), or -III 
(Vps24) were labeled with antibodies recognizing ubiquitin (Ub), 
the early endosome antigen 1 (EEA1) and the late endosomal/
lysosomal marker Lamp2 and analyzed by confocal immuno-
fl  uorescence microscopy. In contrast to siRNA controls (Fig. 1, 
A and B; and Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200702115/DC1), depletion of Hrs resulted in accumu-
lation of ubiquitin on EEA1-positive early endosomes (Fig. 1 C 
and Fig. S1). This was also the case in cells depleted of 
Tsg101, but in addition large ubiquitin-positive EEA1-negative 
structures were seen in close proximity to Lamp2-positive 
membranes (Fig. 1 D and Fig. S1). Cells depleted of Vps22 
generally had a similar phenotype as Tsg101-depleted cells 
(Fig. 1 E and Fig. S1), but the penetrance of the Vps22-depleted 
phenotype was weaker than in cells lacking Tsg101. This could be 
due to different siRNA-mediated knockdown effi  ciency (Fig. 1 G). 
There was no accumulation of ubiquitin on early endosomes in 
Vps24-depleted cells, but large ubiquitin-positive structures 
that either were devoid of endosomal membranes or localized 
close to Lamp2-positive structures could be detected (Fig. 1 F 
and Fig. S1). Similar results were obtained using at least two dif-
ferent siRNA oligonucleotides for each protein. We used siRNA 
against the Vps24 subunit of the ESCRT-III complex, found to 
form a sub-complex with Vps2/CHMP2 (Babst et al., 2002; von 
Schwedler et al., 2003), as two isoforms of Vps2/CHMP2 are 
expressed in HeLa cells (unpublished data). Depletion of one 
ESCRT subunit did not affect the expression levels or stability 
of subunits of other ESCRT complexes (unpublished data).
Together, our data show that depletions of Hrs or the 
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of the ESCRT-III subunit Vps24, result in accumulation of ubiq-
uitinated proteins on early endosomes, probably representing 
internalized mono-ubiquitinated plasma membrane proteins or 
components of the sorting machinery. In addition, large ubiquitin-
positive structures, often found in close proximity to the lyso-
somal marker Lamp2, accumulate in cells depleted of Tsg101, 
Vps22, and Vps24.
p62-positive structures accumulate in cells 
depleted of Tsg101 and Vps24
To further investigate the nature of the large ubiquitin-positive 
EEA1-negative structures found in ESCRT-depleted cells, we 
used cells treated with siRNA against Tsg101 and Vps24 for 
further studies. We fi  rst asked whether p62 and Alfy, proteins 
known to associate with cytoplasmic ubiquitin-positive structures 
Figure 1.  Non-endosomal ubiquitin-positive structures 
accumulate in ESCRT depleted cells. HeLa cells were left 
untransfected (A) or transfected with control (B), Hrs (C), 
Tsg101 (D), Vps22 (E), or Vps24 (F) siRNA for 5 d and 
processed for immunoﬂ  uorescence microscopy. Cells were 
labeled with antibodies against EEA1 (blue), ubiquitin (mono 
and poly-Ub, red), and Lamp2 (green). Colocalization 
between EEA1 and Ub is indicated in purple and between 
Ub and Lamp2 in yellow. Bar, 10 μm. Single channel images 
of the insets are shown in Fig. S1 (available at http://
www.jcb.org/cgi/content/full/jcb.200702115/DC1). 
(G) Knock-down efﬁ  ciencies were analyzed by Western 
blotting. Equal loading was veriﬁ   ed by anti-α-tubulin 
immunoblotting.JCB • VOLUME 179 • NUMBER 3 • 2007  488
(Simonsen et al., 2004; Bjorkoy et al., 2005), accumulate in 
cells depleted of Tsg101 or Vps24. As can be seen in Fig. 2, 
both p62 (Fig. 2 A) and Alfy (Fig. 2 B) were found to associ-
ate with the ubiquitin-positive structures that accumulate in 
ESCRT-depleted cells. Both the number and size of p62-positive 
structures were dramatically increased in Tsg101- and Vps24-
depleted cells, as quantifi  ed from more than 300 cells using 
ImageJ software. The p62-positive particles were grouped accord-
ing to their size, and the numbers per 100 cells are presented in 
Fig. 2 C. Control cells had an average of 355p62-positive struc-
tures per 100 cells, with only 29 having an area above 2 μm
2. 
In contrast, cells depleted of Tsg101 or Vps24 had on average 
1,251 and 1,605 p62-positive structures, with 263 and 332 above 
2 μm
2, respectively. Thus, depletion of ESCRT subunits leads 
to both increased numbers and sizes of ubiquitin-, p62- and 
Alfy-positive aggregates or inclusions.
Autophagic degradation is impeded 
in Tsg101- and Vps24-depleted cells
Formation of ubiquitin-positive aggregates, as seen in Tsg101- 
and Vps24-depleted cells, could be caused either by increased 
protein synthesis or decreased protein degradation. The ubiquitin–
proteasome system is the principal means of eliminating 
polyubiquitinated damaged or misfolded proteins, but also 
loss of autophagy was recently found to lead to accumulation 
of ubiquitin-positive inclusions and cause neurodegeneration 
Figure 2.  p62- and Alfy-positive structures accumulate in cells depleted of Tsg101 or Vps24. HeLa cells transfected with siRNA against Tsg101 or Vps24 
were ﬁ  xed, permeabilized, and stained with antibodies against ubiquitin (red) and p62 (green) (A) or against ubiquitin (green) and Alfy (red) (B). Colocal-
ization is indicated in yellow. Bar, 10 μm. (C) The number and size (area) of p62-positive particles were quantiﬁ  ed using ImageJ software. Approximately 
100 cells from three different experiments (n = 334 (control), 309 (Tsg101), and 246 (Vps24)) were used for the quantiﬁ  cation and the data is presented 
as average number per 100 cells. Error bars = SEM.MVBs ARE REQUIRED FOR AGGREGATE CLEARANCE • FILIMONENKO ET AL. 489
in mouse models (Hara et al., 2006; Komatsu et al., 2006). 
We therefore asked whether protein synthesis, proteasome ac-
tivity, or autophagic degradation was affected by knockdown of 
ESCRT subunits. The total level of protein synthesis, as mea-
sured by incorporation of [
3H]-leucine, was not considerably 
changed in ESCRT-depleted cells (Fig. S2 A, available at http://
www.jcb.org/cgi/content/full/jcb.200702115/DC1). Neither the 
relative mRNA levels of p62 nor LC3-B were signifi  cantly 
increased in ESCRT-depleted cells, as measured by quantitative 
real-time PCR (qRT-PCR) (Fig. S2 B). Proteasome activity was 
analyzed in the absence or presence of the proteasome inhibitor 
PSI in control and ESCRT-depleted cells, and, interestingly, pro-
teasome activity was increased rather than decreased in ESCRT-
depleted cells (Fig. S2 C). This could be due to proteolytic 
cross-talk, induced by inhibition of autophagic degradation in 
ESCRT knockdown cells, as described in the next section.
LC3/Atg8 is a widely used marker for autophagy, as it 
binds specifi  cally to autophagic membranes and remains bound 
throughout the pathway (Kabeya et al., 2000; Mizushima et al., 
2001). p62, known to interact with LC3 and to be degraded by 
autophagy (Bjorkoy et al., 2005; Pankiv et al., 2007), is another 
commonly used autophagy marker. HeLa cells stably expressing 
LC3 fused to GFP (Bampton et al., 2005) were transfected with 
control, Tsg101, or Vps24 siRNA, and the levels of GFP-LC3 
and p62 were analyzed by confocal microscopy. Although p62 
and GFP-LC3 colocalized on small cytoplasmic structures in 
control cells (Fig. 3 A, inset), a massive accumulation of these 
two proteins were seen in cells depleted of Tsg101 or Vps24 
(Fig. 3, B and C, insets). Both the overall levels of p62 and GFP-
LC3 and their degree of colocalization were increased in Tsg101- 
and Vps24-depleted cells, as quantifi  ed from three independent 
experiments (Fig. 3 D). p62 accumulation was also seen upon 
immunoblotting of cell lysates from ESCRT-depleted HeLa 
(Fig. 3 E), HepII, and U2OS cells (unpublished data). Using dif-
ferential detergent extraction, a technique often used as a quanti-
tative measure of protein inclusion formation (Scherzinger et al., 
1997; Wanker et al., 1999), we observed a shift in p62 from less 
stringent extraction buffers (1% Triton-X-100, soluble) into 2% 
SDS (insoluble) in ESCRT-depleted cells, representing a shift 
into a more aggregated conformation (Fig. 3 E). p62 accumula-
tion was also seen in cells depleted of Atg5 (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200702115/DC1), and 
although the mechanism responsible for p62 accumulation is 
clearly different in Atg5- and ESCRT-depleted cells, these data 
further demonstrate that p62-positive aggregates form when 
autophagic turnover is inhibited HeLa cells.
As GFP-LC3 has the potential to associate with membrane-
free aggregates (Kuma et al., 2007), probably due to its complex 
formation with p62 (Bjorkoy et al., 2005; Pankiv et al., 2007), a 
better way to analyze cellular autophagy levels is to measure the 
ratio between the 18-kD cytosolic and 16-kD lipidated auto-
phagosome-bound form of LC3, LC3-I, and LC3-II, respectively 
(Kabeya et al., 2000, 2004). As can be seen in Fig. 3 E, 
increased levels of LC3-II were detected in cells depleted of 
Tsg101 or Vps24. This could in principle be caused either 
by elevated levels of autophagy or decreased degradation. How-
ever, the endogenous LC3-II level was similar in control and 
ESCRT-depleted cells treated with the proton ATPase inhibitor 
Bafi  lomycin A, known to inhibit lysosomal degradation (Fig. 3 F). 
If ESCRT knock-down lead to increased levels of autophagy, 
we would expect the LC3-II levels to be higher in ESCRT-depleted 
than control cells treated with Bafi  lomycin A. Moreover, the fact 
that LC3-B mRNA levels were unaffected in ESCRT-depleted 
cells compared with control cells (Fig. S2 B) also indicates, 
although indirectly, that LC3 synthesis is unchanged.
To further investigate whether autophagic degradation is 
inhibited in cells depleted for ESCRTs we took advantage of a 
recently developed double-tagged mCherry-GFP-LC3 construct 
(dtLC3) (Pankiv et al., 2007), which is detected as yellow fl  uor-
escent (green merged with red) in nonacidic structures (auto-
phagosomes and amphisomes) and as red only in autolysosomes 
due to quenching of GFP in these acidic structures (see Fig. 4 A, 
cartoon). Whereas 50% of the total dtLC3 signal was red in control 
cells (Fig. 4, B and E), only 20% red was detected in Tsg101- 
(Fig. 4, C and E) and Vps24-depleted cells (Fig. 4, D and E). 
This indicates that transport of mCherry-GFP-LC3 to acidic lyso-
somes, i.e., formation of autolysosomes, is inhibited in ESCRT-
depleted cells. Depletion of Tsg101 and Vps24 also inhibited 
starvation-induced degradation of long-lived proteins in HeLa 
cells (Fig. 4 F). Compared with control cells, there was an average 
60 and 43% reduction of the level of starvation-induced de  g-
radation in Tsg101- and Vps24-depleted cells, respectively. 
Collectively, our data strongly indicate a general requirement 
for functional MVBs in autophagy.
Formation of autolysosomes is inhibited 
in ESCRT-depleted cells
Our data indicate that ubiquitin-positive, p62-positive aggregates 
accumulate in ESCRT-depleted cells due to defective autophagic 
degradation, but at what step is this pathway impeded? Although 
the classical view is that autophagosomes fuse directly with 
lysosomes, autophagosomes have also been found to undergo 
fusions with earlier parts of the endocytic pathway (Tooze et al., 
1990; Punnonen et al., 1993; Liou et al., 1997; Berg et al., 1998) 
and the term amphisome is used to describe pre-autolysosomal 
compartments containing both autophagic and endocytic mate-
rial (Gordon and Seglen, 1988). Because the ESCRT-complexes 
are required for proper formation of MVBs, it is likely that loss 
of ESCRT subunits inhibits either the fusion of autophagosomes 
with MVBs or fusion of amphisomes with lysosomes.
To address this issue we used immunoelectron microscopy 
(EM). To perform double-labeling experiments with autophagic 
and endosomal markers, we used HeLa cells stably expressing 
GFP-LC3 (Bampton et al., 2005). Cryosections were incubated 
with antibodies against GFP and the MVB/late endosome marker 
lyso-bisphosphatidic acid (LBPA), and the presence of amphi-
somes could then be scored based on both LC3-LBPA colocal-
ization and morphology (Fig. 5). GFP-LC3 and LBPA positive 
amphisomes were detected in control cells (Fig. 5 A), but more 
frequently in cells lacking Tsg101 (42% increase) (Fig. 5, B, 
D, and F) and Vps24 (29% increase) (Fig. 5, C and F). In ad-
dition, clusters of double-membrane structures, consisting of 
autophagosomes and tubular structures which might represent 
phagophores, all labeling strongly for GFP-LC3, are typically JCB • VOLUME 179 • NUMBER 3 • 2007  490
found in Tsg101-depleted cells (seen in  25% of the cells) 
(Fig. 5, B and E), but were not so prominent in Vps24-depleted 
cells and never seen in control cells. Increased levels of am-
phisomes in ESCRT-depleted cells, visualized as colocaliza-
tion between Alfy and LBPA, was also found using confocal 
immunofluorescence (IF) microscopy (Fig. S4, available at 
Figure 3.  Autophagic degradation is impeded in Tsg101- and Vps24-depleted cells. HeLa cells stably expressing GFP-LC3 (green) were transfected with 
control (A), Vps24 (B), or Tsg101 (C) siRNA for 5 d and processed for immunoﬂ  uorescence analysis. Cells were labeled with antibodies against p62 (red) 
and analyzed by confocal microscopy. Colocalization is indicated in yellow. Bar, 10 μm. (D) The total level of p62 and GFP-LC3 (normalized to control cells) 
and their degree of colocalization (% of total) in control and Tsg101- and Vps24-depleted cells were quantiﬁ  ed using the Zeiss LSM 510 Meta software. 
30 cells from three independent experiments were used for quantiﬁ  cation. Error bars = SEM. (E) Western blot showing accumulation of LC3-II and p62 in 
HeLa cells depleted of Vps24 and Tsg101. p62 also accumulates in the insoluble fraction (bottom picture), indicating a shift to a more aggregated form upon 
depleted of Vps24 and Tsg101. (F) Western blot showing that LC3-II levels were similar in control and Vps24-depleted cells treated with Baﬁ  lomycin A.MVBs ARE REQUIRED FOR AGGREGATE CLEARANCE • FILIMONENKO ET AL. 491
http://www.jcb.org/cgi/content/full/jcb.200702115/DC1). In some 
cells Alfy positive structures seemed to be surrounded by LBPA-
positive membranes (Fig. S4 D), suggesting that protein aggre-
gates may accumulate in amphisomes when the MVB pathway is 
impeded. However, due to the lower resolution of the confocal 
microscope we cannot distinguish fused (amphisomes) from 
docked autophagosome–endosome vesicles, and EM analysis is 
thus a better way of addressing this issue.
To determine whether p62-positive structures could be 
found within autophagic vesicles, cryosections of HeLa cells 
treated with control, Tsg101, or Vps24 siRNA were incubated 
with antibodies against p62, followed by colloidal gold-labeled 
secondary antibodies. p62-positive structures were detected 
within amphisomes both in control cells and in cells depleted 
of Tsg101 or Vps24 (Fig. 6, E and F). In addition, clusters of 
small vesicular–tubular elements and larger vesicles of typical 
endosomal morphology were often found within p62-labeled 
areas in Tsg101- and Vps24-depleted cells (Fig. 6, A and B). 
Membrane-free dense p62-positive cytosolic aggregates were 
also frequently found in these cells (Fig. 6, C and D; and Table I), 
but never in control cells (Table I).
Collectively, our EM and IF analyses indicate that auto-
phagosomes and amphisomes accumulate in ESCRT-depleted 
cells, but also clusters of endosomal and autophagic vesicles and 
membrane-free aggregates are formed.
Ubiquitin- and p62-positive aggregates 
accumulate in CHMP2B mutant cells
Mutations in the ESCRT-III subunit CHPM2B were recently 
linked to FTD (Skibinski et al., 2005) and ALS (Parkinson 
et al., 2006). Sequencing of CHMP2B in a Danish pedigree 
with autosomal-dominant FTD identifi  ed a G-to-C transition 
in the acceptor splice site of exon 6 in CHMP2B in affected 
individuals, generating two aberrant transcripts. One transcript 
contained the 201-bp intronic sequence in between exon 5 and 6 
(CHMP2B
Intron5), resulting in a premature stop codon, and 
Figure 4.  Formation of autolysosomes is inhibited in cells depleted of Tsg101 or Vps24. (A) The double-tagged LC3 protein (mCherry-GFP-LC3) will emit yellow 
(green merged with red) ﬂ  uorescence in non-acidic structures and appear as red only in the autolysosomes due to quenching of GFP in these acidic structures. 
(B–F) HeLa cells were transfected with control (B), Tsg101 (C), or Vps24 (D) siRNA for 4 d and then with mCherry-GFP-LC3 for another 24 h before confocal 
microscopy analysis. Bar, 5 μm. (E) The mCherry-LC3 (red) signal was quantiﬁ  ed in  30 cells with similar expression levels from three independent experi-
ments using the Zeiss LSM 510 Meta software and the data are presented as % of total mCherry-GFP-LC3. Error bar = SEM. (F) Degradation of [
14C]-valine-
labeled proteins in cells incubated in complete medium (control), serum- and amino acid-deﬁ  cient medium (starve), or starvation media in the presence of 
3-methyl adenine (3-MA) to inhibit autophagic degradation. Average degradation per hour from four experiments done in duplicates ±1 SEM are shown. JCB • VOLUME 179 • NUMBER 3 • 2007  492
thus a 36-amino acid C-terminal truncation. The other had a 10-bp 
deletion due to use of a cryptic splice site located 10 bp from the 
5′ end of exon 6 (CHMP2B
∆10), leading to the fi  nal 36 amino 
acids of CHMP2B being replaced with an abnormal 29-amino 
acid C terminus (Skibinski et al., 2005).
The patient brains from this family contain ubiquitin and 
p62-positive inclusions (Holm et al., 2007) and therefore, one 
hypothesis that could explain the neurodegenerative phenotype 
seen in these patients is that mutations in CHMP2B result in 
repressed autophagic degradation. To investigate this hypothesis, 
HeLa cells were transfected with myc-tagged wild-type or 
mutant CHMP2B, stained with antibodies against myc, ubiqui-
tin, and p62, and analyzed by confocal microscopy. As can be 
seen in Fig. 7 A, untransfected cells and cells expressing wild-
type CHMP2B showed weak staining for ubiquitin and p62 on 
small cytoplasmic structures. In contrast, the levels of ubiquitin 
Figure 5.  Autophagosomes and amphisomes do form in ESCRT-depleted cells. HeLa cells stably expressing GFP-LC3 were transfected with control (A), 
Tsg101 (B, D, and E), or Vps24 (C) siRNA and processed for immuno-EM analysis. Cryosections were incubated with antibodies against GFP (15-nm 
gold) and LBPA (10-nm gold). Amphisomes (Am), characterized by their content of electron-dense LC3-positive areas and intraluminal vesicles, were ob-
served in both control (A) and ESCRT-depleted cells (B and C). (D) In the Tsg101-depleted cells we found large clusters of more typical autophagosomes 
(Au) and (E) clusters of double-membrane structures, consisting of autophagosomes and tubular structures which might represent phagophores, all label-
ing strongly for GFP-LC3. We never observed similar clusters in control cells and very rarely in Vps24-depleted cells. Bars, 200 nm. (F) Quantiﬁ  cation of 
amphisomes in control cells and cells depleted for Tsg101 or Vps24. Approximately 20 cells were included per siRNA depletion per experiment (n = 3). 
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and p62 were strongly increased (20–40 times) in cells express-
ing CHMP2B
Intron5 (Fig. 7, B and D) and CHMP2B
∆10 (Fig. 7, 
C and D). Increased p62 levels were also detected by immuno-
blotting in cells expressing CHMP2B
Intron5 compared with mock-
transfected cells or cells transfected with wild-type CHMP2B 
(Fig. 7 E). Although the transfection effi  ciency was below 30%, the 
total expression levels of CHMP2B
wt and CHMP2B
Intron5 were 
equal (Fig. 7 E). p62 was also found to accumulate in the 
Triton-X-100 insoluble fraction in CHMP2B
Intron5-expressing 
cells, as determined by differential detergent extraction (un-
published data). As in ESCRT-depleted cells, increased levels 
of GFP-LC3 were seen in HeLa GFP-LC3 cells expressing 
CHMP2B mutants (Fig. S5, B and C, available at http://www
.jcb.org/cgi/content/full/jcb.200702115/DC1) compared with 
un  transfected cells and cells expressing wild-type CHMP2B 
(Fig. S5 A).
We then used immuno-EM to further characterize the mor-
phology of p62-positive structures formed in cells expressing 
CHMP2B mutants. In cells depleted of Tsg101 and Vps24, 
p62-positive autophagosomes, amphisomes, clusters of small 
vesicular–tubular elements, and membrane-free dense p62-
positive cytosolic aggregates were found (Fig. 6). Similar 
p62-positive structures were detected in cells expressing the 
CHMP2B
Intron5 mutant and a p62-positive cluster of small vesic-
ular–tubular elements can be seen in Fig. 7 F. Collectively, our 
results indicate that expression of CHMP2B mutants inhibit 
autophagic degradation, leading to accumulation of ubiquitin, 
p62, and GFP-LC3.
Figure 6.  Immuno-EM of p62-positive struc-
tures in Vps24- and Tsg101-depleted cells. 
Cryosections of HeLa cells transfected with 
Vps24 (A, C, and E) or Tsg101 (B, D, and F) 
siRNA were incubated with antibodies against 
p62 (15-nm protein A gold, 10-nm in D). Mem-
brane-free p62-positive aggregates (C and D) or 
p62-positive structures contained within dense 
clusters of vesicular-tubular elements (A and B) 
were detected. Vesicles with early endosomal 
morphology (EE) or multivesicular appearance 
(MVB) associated with these clusters. We also 
observed p62 labeling in electron-dense struc-
tures sequestered within amphisomes in cell 
depleted of Vps24 (E) or Tsg101 (F). The amphi-
somes typically consist of an electron-dense p62 
positive body (E and F, arrowhead), and a multi-
vesicular endosomal structure (E and F, arrow). 
Bars, 200 nm.
Table I. Membrane-free p62-positive aggregates accumulate in 
ESCRT depleted cells
Aggregates per cell ± SD
Control 0 ± 0
Tsg101 siRNA  0.095 ± 0.037*
Vps 24 siRNA 0.100 ± 0.050*
The number of p62-positive aggregates in control, Tsg101, and Vps24 siRNA 
treated cells was quantiﬁ  ed by counting approximately 200 randomly chosen 
cell proﬁ  les per group from 3 different experiments. *, P ≤ 0.05 according 
to t test.JCB • VOLUME 179 • NUMBER 3 • 2007  494
TDP-43 accumulates in cytoplasmic 
inclusions in ESCRT-depleted cells
FTLD-U and ALS are characterized by abnormal accumulation of 
p62- and ubiquitin-positive, tau- and α-synuclein-negative neuronal 
cytoplasmic inclusions, and TDP-43 was recently identifi  ed as 
the major ubiquitinated protein of these diseases (Arai et al., 
2006; Neumann et al., 2006). We therefore asked whether TDP-43 
accumulates in cytoplasmic aggregates in HeLa cells depleted of 
Figure 7.  Ubiquitin and p62 positive structures accumulate in cells expressing CHMP2 mutants. HeLa cells transfected with myc-tagged wild-type CHMP2B 
(A), CHMP2B
Intron5 (B), or CHMP2B
Δ10 (C) were labeled with antibodies against c-Myc (red), ubiquitin (green), and p62 (blue) and analyzed by confocal 
microscopy. Single channel images in black and white are shown. Bars,10 μm. (D) Total levels of p62 in these cells were quantiﬁ  ed in 20 cells from three 
independent experiments using the Zeiss LSM 510 Meta software and the average normalized to the average p62 level in control (mock transfected) cells. 
Error bars = SEM. (E) Western blot analysis showing accumulation of p62 in cells transfected with myc-CHMP2B
Intron5 compared with mock-transfected cells 
(control) and cells transfected with CHMP2B
wt. (F) Immuno-EM showing p62-positive aggregates containing dense clusters of vesicular–tubular structures in 
cells transfected with myc-CHMP2B
Intron5. Bar, 200 nm.MVBs ARE REQUIRED FOR AGGREGATE CLEARANCE • FILIMONENKO ET AL. 495
Tsg101 or Vps24. In control cells, TDP-43 was mainly detected 
in the nucleus and in a few cells also in small cytoplasmic 
structures positive for p62 (Fig. 8 A). In contrast, in cells de-
pleted of Tsg101 (Fig. 8 B) or Vps24 (Fig. 8 C), TDP-43 accu-
mulated in aggregates that also stained positive for p62 and 
ubiquitin. Thus, our data show, for the fi  rst time, a link between 
TDP-43–positive inclusions and depletion of proteins required 
for MVB formation and autophagic degradation.
We did not detect TDP-43 in the cytoplasmic ubiquitin-, 
p62-positive structures found in cells expressing CHMP2B
Intron5 
and CHMP2B
∆10 (Fig. S5, E and F). This is in line with recent 
data showing that ubiquitin-positive inclusions in patients from 
the Danish family with the CHMP2B mutation are TDP-43 
negative (Holm et al., 2007). This is in contrast to other cases of 
FTLD-U, and might suggest that two distinct effects of MVBs 
may be occurring in TDP-43–positive and –negative FTLD-U.
Vps24 is required for clearance 
of Huntingtin polyQ inclusions
Our data indicate that functional MVBs play an important role 
in preventing formation of ubiquitin-positive inclusions, and 
we next asked whether clearance of expanded polyQ inclusions 
associated with HD also requires functional MVBs. Condi-
tional expression of exon 1 of Huntingtin with a pathogenic 
polyglutamine stretch of 65 or 103 repeats fused to monomeric 
CFP (Htt 65Q- or 103Q-mCFP) in HeLa and Neuro2a (N2a) 
cell lines was recently shown to lead to formation of inclusions 
that were readily cleared by autophagy within 5 d after shutting 
off protein expression (Yamamoto et al., 2006). The time re-
quired for aggregate clearance was comparable to the clearance 
observed in primary neurons generated from an inducible 
mouse model of HD (Yamamoto et al., 2000; Martin-Aparicio 
et al., 2001). We therefore used these cells to determine whether 
inclusion clearance still occurred in cells depleted of Vps24. 
This was analyzed by fi  lter-trap experiments (amount of SDS-
insoluble material) (Fig. 9, A and C) or confocal analysis (num-
ber of cells having aggregates) (Fig. 9 B). Although 25–30% of 
HeLa Htt103Q-mCFP transfected with control siRNA had 
inclusions in the absence of doxycycline (control-dox), only 
5% of the control cells had visible inclusions after 3 d of dox 
treatment (control+dox) (Fig. 9 B). Aggregate clearance was 
severely reduced in cells depleted of Vps24, as 15–20% of the 
Figure 8.  TDP-43 accumulates in cytoplasmic ubiquitin-positive structures in Tsg101- and Vps24-depleted cells. HeLa cells transfected with control 
(A), Tsg101 (B), or Vps24 (C) siRNA were ﬁ  xed, permeabilized, and stained with antibodies against TDP-43 (green), ubiquitin (red), and p62 (blue). Single 
channel images in black and white are shown. Colocalization of all proteins is indicated in white in the merged picture. Bars, 10 μm.JCB • VOLUME 179 • NUMBER 3 • 2007  496
cells had visible Htt103Q-mCFP inclusions after 3 d of dox 
treatment (Vps24+dox) (Fig. 9 B). Similar results were ob-
tained using HeLa Htt65Q-mCFP cells, as analyzed by fi  lter-
trap experiments (Fig. 9 A). Moreover, depletion of Vps24 in 
mouse neuronal cells (N2a Htt103Q-mCFP) also inhibited 
inclusion clearance compared with control cells after 3 d of dox 
treatment (Fig. 9 C).
Together, our data indicate that clearance of Htt-positive 
inclusions depends on functional MVBs. This adds to previous 
reports showing that pathogenic Htt proteins are cleared by auto-
phagy (Ravikumar et al., 2004; Iwata et al., 2005; Ravikumar 
and Rubinsztein, 2006; Yamamoto et al., 2006) and reveals an 
important role of ESCRT complexes in autophagic degradation 
of protein aggregates.
Discussion
The ESCRT complexes are involved in sorting of endocytosed 
ubiquitinated integral membrane proteins into the ILVs of MVBs. 
Their depletion in mammalian cells has been found to inhibit 
degradation of proteins like the EGF-R and results in MVBs 
with abnormal morphology (Slagsvold et al., 2006). However, 
little is known about the role of MVBs, and the consequence of 
depleting ESCRT subunits, for autophagic degradation. In this 
study we show that siRNA-mediated depletion of ESCRT sub-
units inhibits autophagic degradation, leading to accumulation 
of large ubiquitin-positive protein aggregates, also containing 
Alfy and p62, proteins known to closely associate with cyto-
plasmic ubiquitin-positive structures and autophagic membranes 
(Simonsen et al., 2004; Bjorkoy et al., 2005). We show that 
degradation of the autophagic membrane protein Atg8/LC3-II 
and the autophagic substrate p62 is inhibited and that there is 
a shift toward p62 insolubility, indicative of a more aggregated 
conformation, in cells depleted of Tsg101 and Vps24. Autophago-
somes and amphisomes are formed in ESCRT-depleted cells, 
but the formation of autolysosomes is inhibited. This is in line 
with previous studies, showing that mutations in Vps class C 
proteins (Rieder and Emr, 1997; Lindmo et al., 2006) and the 
class E Vps proteins Vps4p/SKD1 (Shirahama et al., 1997; 
Nara et al., 2002; Besteiro et al., 2006) and CeVPS-27 (Roudier 
et al., 2005) impede the formation of autolysosomes. In addi-
tion, we observed clusters of small vesicular–tubular elements 
and membrane-free dense p62-positive cytosolic aggregates 
in ESCRT-depleted cells. Although we cannot exclude the 
possibility that ESCRTs also have non-MVB related func-
tions in autophagy, our data strongly indicate that dysfunctional 
MVBs inhibit autophagic degradation, leading to formation 
of large aggregates that eventually may cause neurodegenera-
tive disease.
The ESCRT-III subunit CHMP2B, forming a complex 
with Vps24 (Babst et al., 2002; von Schwedler et al., 2003), was 
recently found to be mutated in a large Danish family with 
familial FTD (Skibinski et al., 2005) and in patients with ALS 
(Parkinson et al., 2006). CHMP2B mutations are not a common 
cause of FTD, as several studies have failed to identify CHMP2B 
mutations in FTD patients (Cannon et al., 2006; Rizzu et al., 
2006). We show here that cells expressing CHMP2B mutants 
corresponding to the mutation found in the Danish FTD patients 
are characterized by accumulation of ubiquitin, p62, and LC3, 
indicating that autophagic degradation is impeded in these cells. 
Our data thus suggest a possible explanation to the observed neuro-
degenerative phenotypes seen in CHMP2B mutant patients. 
Ubiquitin and p62 are common components of protein inclu-
sions associated with neurodegenerative disease (Talbot and 
Ansorge, 2006) and are found in the brains of the Danish FTD 
patients (Holm et al., 2007). However, the ubiquitin- and p62-
positive inclusions observed in the Danish FTD patient brains 
with the CHMP2B mutation occur at low frequency as com-
pared with other cases of FTLD-U and are generally observed 
mostly in the hippocampus, which is not a site of the neuro-
degenerative pathology (Holm et al., 2007). This suggests that 
although autophagy may be impaired globally, leading to cell 
death, the formation of ubiquitin- and p62-positive inclusions 
occurs only in a subset of cells in vivo. This could be because 
the majority of cells with such inclusions have degenerated 
by the end stage of the disease that is observed in post mortem 
Figure 9.  Vps24 is required for efﬁ  cient clearance of Htt inclusions. 
HeLa cells expressing HttQ65-mCFP (A) or HttQ103-mCFP (B) and N2a cells 
expressing HttQ103-mCFP (C) were transfected with control or Vps24 siRNA 
for 2 d and then incubated in the absence or presence of doxycycline for 
3 d to turn off expression of HttQ65/Q103-mCFP. Vps24 depletion was 
determined by Western blot analysis. (A and C) Clearance of SDS-insoluble 
Htt inclusions was analyzed by ﬁ  lter-trap assays. (B) Alternatively, ag-
gregate clearance was analyzed by confocal quantiﬁ  cation of the number 
of HeLa HttQ103 cells having visible inclusions after 3 d in the absence or 
presence of dox. 300 cells from three independent experiments were 
counted for each condition. Error bars = SD.MVBs ARE REQUIRED FOR AGGREGATE CLEARANCE • FILIMONENKO ET AL. 497
material, or that the inclusions are a protective mechanism 
against impaired autophagy.
Ubiquitin-positive tau-negative neuronal cytoplasmic in-
clusions are common pathological features in FTLD-U and ALS, 
and TDP-43 was recently identifi  ed as the major ubiquitinated 
protein in these disorders (Arai et al., 2006; Neumann et al., 
2006). We here show that TDP-43 accumulates in cells depleted 
of Tsg101 and Vps24, suggesting that impaired MVB function 
could have a role in TDP-43 aggregate formation in FTLD-U 
and ALS. It is not clear from our experiments if TDP-43 itself is 
degraded via autophagy, although this could be one explanation 
for its accumulation. In contrast to other cases of FTLD-U, the 
ubiquitin-positive inclusions found in patients from the Danish 
CHMP2B mutant family are TDP-43 negative (Holm et al., 2007). 
We also failed to detect TDP-43 in the cytoplasmic ubiquitin-, 
p62-positive structures that accumulate in cells expressing mu-
tant CMHP2B, suggesting that the molecular mechanisms re-
sponsible for accumulation of p62 and TDP-43 differ.
Using a cell-based system for HD, we show that ESCRTs 
(Vps24) are required also for effi  cient clearance of the Htt 
polyQ aggregates, both in human HeLa and mouse neuronal 
cells. It has previously been shown that the autophagic pathway 
is responsible for clearance of Htt polyQ aggregates (Ravikumar 
et al., 2004; Iwata et al., 2005; Ravikumar and Rubinsztein, 2006; 
Yamamoto et al., 2006), but our results show, for the fi  rst time, 
that functional MVBs and a Vps class E protein are required for 
effi  cient clearance of Htt inclusions.
Recently, it was found that mice with neuronal-specifi  c 
defi  ciencies for Atg5 or Atg7, proteins known to be essential for 
autophagy, are characterized by accumulation of cytoplasmic 
inclusion bodies and a neurodegenerative phenotype (Hara 
et al., 2006; Komatsu et al., 2006). Our results indicate that de-
pletion of ESCRT proteins likely will result in a similar pheno-
type, but do not allow us to conclude about when these proteins 
become ubiquitinated. There is little or no evidence to date 
showing that polyubiquitinated proteins are normally degraded 
by autophagy and it is probably more likely that proteins that are 
normally turned over by autophagy become polyubiquitinated 
when autophagic degradation is inhibited. However, it was re-
cently found that induction of autophagy leads to enhanced 
delivery of ubiquitin to lysosomes and that this correlates with en-
hanced lysosomal bactericidal capacity (Alonso et al., 2007), 
which might support the idea that polyubiquitinated proteins are 
autophagic substrates. p62, containing a ubiquitin-binding UBA 
domain (Vadlamudi et al., 1996), would be an excellent candidate 
for recognition and targeting of polyubiquitin linked proteins to 
the autophagic pathway (Fig. 10).
In conclusion, we have shown that depletion of ESCRT sub-
units or overexpression of CHMP2B mutant proteins inhibit auto-
phagic degradation, leading to accumulation of ubiquitin-positive 
aggregates that contain proteins associated with neurodegenera-
tive disease. Our data indicate that functional MVBs are required to 
prevent accumulation of abnormal proteins that can disrupt neural 
function and ultimately lead to neurodegeneration.
Figure 10.  Model for autophagic degradation 
in control and ESCRT-depleted cells. In control 
cells, cytoplasmic cargo (proteins and organ-
elles) is sequestered by an isolation membrane/
phagophore, forming double-membrane auto-
phagosomes that can fuse with MVBs, forming 
amphisomes. Amphisomes, containing both 
endocytic and auto  phagic cargo, then fuse with 
lysosomes, forming autolysosomes, where the 
content is degraded. Autophagosomes may 
also fuse directly with lysosomes, although the 
amphisome pathway seems to be the   major 
pathway in HeLa cells. The ESCRT complexes 
are required for proper sorting and degrada-
tion of ubiquitinated integral membrane proteins 
(e.g., EGFR) and for proper MVB morphology, 
and depletion of ESCRT subunits results in 
the formation of aberrant MVBs (morphology 
depending of which ESCRT subunit is depleted) 
(red box A). Degradation of auto  phagic cargo 
is also inhibited in ESCRT-  depleted cells, pro-
posedly because of inhibited formation of 
auto  lysosomes (red box B), although autophago-
somes and amphisomes are still formed. 
In addition, large p62- and ubiquitin-positive 
membrane-free aggregates accumulate in ESCRT-
depleted cells (red box C), indicating that con-
tinuous auto  phagic clearance of cytoplasmic 
proteins is important to avoid accumulation of 
ubiquitin-positive aggregates that may cause 
neurodegeneration.JCB • VOLUME 179 • NUMBER 3 • 2007  498
Materials and methods
Cell culture
HeLa cell cultures were maintained as recommended by American Type 
Culture Collection (Manassas, VA). HeLa and N2a cells stably expressing 
a Tet-off inducible exon1 of Htt carrying a polyQ expansion of 65 or 103 
residues, fused to monomeric enhanced CFP at the C termini (Htt 65Q- or 
103Q-mCFP), were cultured as described (Yamamoto et al., 2006) and 
100 ng/ml doxycycline (dox) was used to shut off production of new pro-
tein. HeLa cells stably expressing GFP-LC3 were a gift from Aviva Tolkovsky 
(University of Cambridge, Cambridge, UK; Bampton et al., 2005).
Antibodies
Rabbit antibodies against Hrs (Raiborg et al., 2001), Vps24 (Bache et al., 
2006), and Alfy (Simonsen et al., 2004) have been described before. 
An antibody recognizing human Vps22 was made by injecting rabbits 
with recombinant Vps22 as a fusion with maltose binding protein (MBP) 
(Eurogenetec). The antiserum was afﬁ  nity puriﬁ  ed on Vps22-MBP Afﬁ  -Gel 
beads (Bio-Rad Laboratories). A mouse monoclonal antibody against Tsg101 
was obtained from GeneTex. Rabbit anti-LC3 antibody was a gift from Tamotsu 
Yoshimori (Osaka University, Osaka, Japan). Human anti-early endosomal 
antigen (EEA)1 antiserum was a gift from Ban-Hock Toh (Monash Univer-
sity, Melbourne, Australia). Rabbit anti-lysosomal-associated membrane 
protein (LAMP)2 was a gift from Gillian Grifﬁ  ths (University of Oxford, 
Oxford, UK). Mouse monoclonal anti-lyso-bisphosphatidic acid (LBPA) was 
provided by Jean Gruenberg (University of Geneva, Geneva, Switzerland). 
Guinea pig anti-p62 C-terminal antibody was from PROGEN Biotechnik 
GmbH. Mouse monoclonal antibodies against α-tubulin and against conju-
gated mono- and polyubiquitin (FK2) were from Sigma-Aldrich and Af-
ﬁ  niti Research Products, respectively. Anti-GFP antibody was from AbCam. 
Rabbit anti-TDP-43 antibody was from ProteinTech Group. Rabbit anti-
c-Myc antibody was from Santa Cruz Biotechnology, Inc. Cy2-, Cy3-, 
and Cy5-labeled secondary antibodies were from Jackson Immuno-
Research Laboratories.
Transfection of siRNA oligonucleotides and plasmids
The following previously described siRNA oligonucleotides were used: Hrs 
(Bache et al., 2003), Tgs101 (Bishop et al., 2002), Vps24 (Bache et al., 
2006), and control (Cabezas et al., 2005). Vps22 was depleted by the 
siRNA duplex: sense 5′-C  U  U  G  C  A  G  A  G  G  C  C  A  A  G  U  A  U  A  -3′ and antisense 
5′-U  A  U  A  C  U  U  G  G  C  C  U  C  U  G  C  A  A  G  -3′ (MWG-Biotech). Results were con-
ﬁ  rmed by the use of ON-TARGETplus SMARTpool siRNA (Dharmacon) 
against human Hrs, Tsg101, and Vps22. ON-TARGETplus SMARTpool 
siRNA against human Atg5 and against mouse Vps24 were also used. 
Transfection of HeLa cells with siRNA oligonucleotides was performed as 
described previously (Bache et al., 2003). In brief, the cells were trans-
fected with 40–100 nM siRNA using Oligofectamine (Invitrogen) for 3 d; 
the cells were then replated and left for another 2 d before experiments 
were performed. Speciﬁ  c protein knockdown was demonstrated by running 
equal amounts of cell lysate on SDS-PAGE, followed by Western blotting 
using antibodies against Hrs, Tsg101, Vps22, or Vps24.
HeLa cells were transfected with mCherry-GFP-LC3 after 4 d of 
siRNA transfection and incubated for another 24 h before analysis by 
confocal microscopy. Transfection of HeLa cells with cDNA encoding 
myc-tagged wild-type CHMP2B, CHMP2B
Intron5, or CHMP2B
∆10 in pLNCX2 
(CLONTECH Laboratories, Inc.), or mCherry-GFP-LC3 was performed 
using FuGene6 (Roche), according to the manufacturer’s instruction.
Differential detergent extraction and Western blot analysis
To analyze the cellular levels of different proteins and their solubility, cells 
were ﬁ  rst extracted in ice-cold lysis buffer (50 mM NaCl, 10 mM Tris, 
5 mM EDTA, 0.1% SDS, and 1% Triton X-100 + protease and phosphatase 
inhibitor cocktails), centrifuged (14,000 rpm) for 10 min, and the superna-
tants (soluble fraction) collected. The remaining protein pellets were 
washed with phosphate-buffered saline (PBS) before extraction with 2% 
SDS-containing sample buffer (insoluble fraction). Protein concentrations in 
the soluble fractions were determined and  20 μg of protein per sample 
was loaded and resolved on 15% or 4–20% gradient gels (Pierce Chemi-
cal Co.) followed by electro-blotting to Immobilon-P membranes (Millipore). 
The blots were probed with speciﬁ  c antibodies, which were detected using 
standard ECL reagents. The intensities of the of the different bands ob-
tained were quantiﬁ  ed using the software provided by the ChemiGenius 
imaging system (Syngene) and relative amounts quantiﬁ  ed using tubulin as 
a loading control. 200 nM Baﬁ  lomycin A was added for 8 h to inhibit lyso-
somal degradation where indicated.
Confocal immunoﬂ  uorescence microscopy
HeLa cells grown on coverslips, transfected or not with the indicated siRNA 
or plasmid, were ﬁ  xed in 3% paraformaldehyde, permeabilized with 0.05% 
saponin, and stained for ﬂ  uorescence microscopy as described previously 
(Simonsen et al., 1998). Coverslips were examined using a microscope 
(LSM 510 META; Carl Zeiss MicroImaging, Inc.) equipped with a Neo-Fluar 
100×/1.45 oil immersion objective. Image processing and analysis were 
done with Zeiss LSM 510 software version 3.2, ImageJ (National Institutes 
of Health, Bethesda, MD; http://rsb.info.nih.gov/ij/, 1997–2007), and 
Adobe Photoshop 7.0.
Electron microscopy
HeLa cells, transfected or not with the indicated siRNA or plasmid, were 
ﬁ  xed in 4% formaldehyde/0.2% gluteraldehyde in 0.1 M phosphate buffer 
at room temperature for 40 min, washed, scraped, and pelleted in 12% 
gelatin at 10,000 rpm. Specimens were inﬁ  ltrated with 2.3 M sucrose, 
mounted on silver pins, and frozen in liquid nitrogen. Ultrathin cryosections 
were cut at −110°C (EM FCS ultramicrotome; Leica) and collected with a 
1:1 mixture of 2% methyl cellulose and 2.3 M sucrose. Sections were trans-
ferred to formvar/carbon-coated grids and labeled with antibodies against 
p62 or GFP and LBPA, followed by Protein A conjugates essentially as de-
scribed (Slot et al., 1991). Sections were observed at 60–80 kV using a 
Philips CM10 and a JEOL JEM-1230 electron microscope, equipped with a 
SIS Megaview 3 or Morada camera, respectively. Quantiﬁ  cation of labeling 
was performed by counting gold particles on randomly chosen cell pro-
ﬁ  les. The number of p62-positive aggregates was counted in  200 cells per 
group (control, Tsg101-, and Vps24-siRNA) from three different experiments.
Degradation of long-lived proteins in response to amino acid deprivation
HeLa cells treated with control or siRNA against Tsg101 or hVps24 were 
incubated for 24 h with 0.25 μCi/ml L-[
14C] valine–supplemented media. 
Cells were rinsed three times with PBS to remove unincorporated radio-
isotopes and then chased in fresh complete media containing 10 mM cold 
valine for 2 h to allow degradation of short-lived proteins. Cells were 
rinsed in HBSS + 10 mM Hepes and incubated for 4 h with either com-
plete media or HBSS + 10 mM Hepes + 10 mM Valine ± 10 mM 3-methyl 
adenine (3-MA) (Sigma-Aldrich). Cells were then scraped and, using TCA, 
protein was precipitated from both the incubation media and the cells. 
Proteolysis was assessed as the acid-soluble radioactivity divided by the 
radioactivity maintained in the precipitate.
Promoter shutdown experiments and ﬁ  lter-trap assay
48 h after siRNA transfection, HeLa Htt65Q- or 103Q-mCFP cells or N2a 
Htt103Q-mCFP cells were exposed to 100 ng/ml dox for another 3 d to 
shut down production of new Htt65Q/103Q-mCFP protein and permit 
more than 50% of clearance to occur (Yamamoto et al., 2006). The effect 
of siRNA treatment on polyQ aggregate clearance was analyzed by using 
the membrane ﬁ   lter assay for detection of amyloid-like polyglutamine-
containing protein aggregates, according to the published protocol 
(Scherzinger et al., 1997; Wanker et al., 1999). An anti-GFP antibody was 
used to detect 65Q/103QmCFP. The total protein load was normalized to 
the volume of the soluble fraction. Alternatively, clearance of Htt103QmCFP 
aggregates was analyzed by confocal immunoﬂ  uorescence microscopy. 
The percentage of cell having aggregates was quantiﬁ  ed by counting 300 
cells for each condition from three independent experiments.
Protein synthesis assay
Cells were incubated for 2 h in Hepes medium lacking leucine. The cells 
were then incubated in Hepes medium containing 2 μCi ml
–1 [
3H]-leucine 
for 20 min at 37°C. Cells were extracted with 5% trichloroacetic acid 
(TCA) for 10 min, followed by a wash (5 min) in 5% TCA and subsequently 
dissolved in 0.1 M KOH. The cell-associated radioactivity was measured.
Proteasome assay
Proteasome activity was analyzed using the Proteasome-Glo Cell-based assay 
(Promega), which measures the chymotrypsin-like protease activity associated 
with the proteasome complex, according to the manufacturer’s instruction. 
The proteasome inhibitor PSI (50 μM) was added 5 h before the analysis.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from 5 × 10
5 HeLa cells using the Aurum Total 
RNA mini kit (Bio-Rad Laboratories), according to the manufacturer’s 
instructions. Purity and quantity were measured by optical density. 1 μg total 
RNA was used for cDNA synthesis using the iScript cDNA Synthesis kit 
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reactions containing 10 μl 2× QuantiTect SYBR Green PCR master mix 
(QIAGEN), 2 μl 10× QuantiTect Primer Assay (QIAGEN), and 20 ng 
cDNA (2 ng were used for actin) in 96-well optical plates. The cycling con-
ditions for the LightCycler480 (Roche) were 95°C for 15 min, 40 cycles of 
94°C 15 s, 55°C 20 s, and 72°C 20 s The following prevalidated Quanti-
Tect Primer Assays were used: Hs_SQSTM1_1_SG, Hs_MAP1LC3B_1_SG, 
Hs_ACTB_1_SG, Hs_TBP_1_SG. Real-time efﬁ  ciencies were calculated 
from the slopes of the standard dilution curves. RNA transcription levels 
were determined by the method of direct comparison of CT values (CT > 35 
rejected) and relative quantities calculated by the ∆∆CT equation or trans-
formed into linear form by 2
−∆∆Ct. Transcripts were normalized to the quantity 
of actin and TBP for each condition.
Online supplemental material
Fig. S1 shows single channel images of the insets in Fig. 1. Fig. S2 shows 
that neither protein synthesis, transcription, nor proteasome activity is 
drastically affected by depletion of ESCRT subunits. Fig. S3 shows that 
both the number and size of p62-positive structures increase strongly in 
cells depleted of Atg5. Fig. S4 shows increased colocalization of Alfy and 
LBPA in HeLa cells depleted of ESCRT subunits. Fig. S5 shows that p62 
and GFP-LC3, but not TDP-43 accumulate in cells expressing CHMP2B 
mutants. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200702115/DC1.
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